Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.30

-2.8%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (931)	4/13/2000 3:39:00 AM
From: Doc Bones	Read Replies (1) of 52153

VPHM was a huge stock today, the poster child for sudden crashes. I think this could be a plus in terms of sector evaluation. People are asking themselves now: Is this the end of the world, or is the (bio) sell-off a little overdone? VPHM has $230 Million in the bank, with a market cap of $255 Million. Can you say "limited downside"? There's plenty of good science here too. Even I can evaluate this one (allright, with a little help from my friends.) A very small 4 Million share float makes this a volatile issue, a daytrader's favorite. VPHM has shown big moves in the past, and I think the likely direction for one in the future is clear. It drew a lot of attention today, not exactly favorable, but on reflection I think people will realize that the sell-off went beyond the reasonable, and they may re-examine some other stocks in that light. Doc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next